CoChat

Modeling liver cancer and therapy responsiveness using organoids derived from primary mouse liver tumors

Cao, Wanlu, Liu, Jiaye, Wang, Ling, Li, Meng, Verstegen, Monique M A, Yin, Yuebang, Ma, Buyun, Chen, Kan, Bolkestein, Michiel, Sprengers, Dave, van der Laan, Luc J W, Doukas, Michael, Kwekkeboom, Jaap, Smits, Ron, Peppelenbosch, Maikel P, Pan, Qiuwei · 2019 · Carcinogenesis
Cited by 50

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

The current understanding of cancer biology and development of effective treatments for cancer remain far from satisfactory. This in turn heavily relies on the availability of easy and robust model systems that resemble the architecture/physiology of the tumors in patients to facilitate research. Cancer research in vitro has mainly been based on the use of immortalized 2D cancer cell lines that deviate in many aspects from the original primary tumors. The recent development of the organoid technology allowing generation of organ-buds in 3D culture from adult stem cells has endowed the possibility of establishing stable culture from primary tumors. Although culturing organoids from liver tumors is thought to be difficult, we now convincingly demonstrate the establishment of organoids from mouse primary liver tumors. We have succeeded in culturing 91 lines from 129 liver tissue/tumors. These organoids can be grown in long-term cultures in vitro. About 20% of these organoids form tumors in immunodeficient mice upon (serial) transplantation, confirming their tumorigenic and self-renewal properties. Interestingly, single cells from the tumor organoids have high efficiency of organoid initiation, and a single organoid derived from a cancer cell is able to initiate a tumor in mice, indicating the enrichment of tumor-initiating cells in the tumor organoids. Furthermore, these organoids recapitulate, to some extent, the heterogeneity of liver cancer in patients, with respect to phenotype, cancer cell composition and treatment response. These model systems shall provide enormous opportunities to advance our research on liver cancer (stem cell) biology, drug development and personalized medicine.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/carcin/bgy129

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 50

Metadata

Authors
Cao, W., Liu, J., Wang, L., Li, M., Verstegen, M. M. A., Yin, Y., Ma, B., Chen, K., Bolkestein, M., Sprengers, D., van der Laan, L. J. W., Doukas, M., Kwekkeboom, J., Smits, R., Peppelenbosch, M. P., & Pan, Q.
Venue
Carcinogenesis
Published
2018-10-05
Volume
40
Issue
1
Pages
145-154
ISSN
  • 0143-3334 (ISSN-L)
  • 1460-2180
OpenAlex
W2894807200
Cited by
50
References
10
FWCI
1.52
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Modeling liver cancer and therapy responsiveness using organoids derived from primary mouse liver tumors. https://app.cochat.ai/papers/10.1093/carcin/bgy129
The paper
Cao, W., Liu, J., Wang, L., Li, M., Verstegen, M. M. A., Yin, Y., Ma, B., Chen, K., Bolkestein, M., Sprengers, D., van der Laan, L. J. W., Doukas, M., Kwekkeboom, J., Smits, R., Peppelenbosch, M. P., & Pan, Q. (2019). Modeling liver cancer and therapy responsiveness using organoids derived from primary mouse liver tumors. Carcinogenesis. https://doi.org/10.1093/carcin/bgy129

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.